Evidence map›Paper›PMID 31529796›Full record

ArticleCurrent protocols in toxicology2019

Assembly and Application of a Three-Dimensional Human Corneal Tissue Model.

Tina B McKay, Andrew Ford, Siran Wang, Dana M Cairns, Rachael N Parker, Phillip M Deardorff, Chiara E Ghezzi, David L Kaplan

Open access · greenAbstract read
In one paragraph

Article in Current protocols in toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. ACS omega · 2022
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tina B McKayDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts.
Andrew FordDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts.
Siran WangDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts.
Dana M CairnsDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts.
Rachael N ParkerDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts.
Phillip M DeardorffDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts.
Chiara E GhezziDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts.
David L KaplanDepartment of Biomedical Engineering, Tufts University, Medford, Massachusetts.
Tufts University · US

Funding

Translational Bioreactors - Engineering Complex TissuesP41EB002520 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2004 to 2018
$16.7M
Tissue Engineering Resource Center: TTDP41EB027062 · NIBIB · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gordana Vunjak-Novakovic · 2019 to 2026
$12.6M
Tissue Engineering Cornea ReplacementsR01EY020856 · NEI · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2010 to 2016
$2.7M
NEI NIH HHS R01 EY020856NIBIB NIH HHS P41 EB002520NIBIB NIH HHS P41 EB027062
6 · The paper itself

Abstract

The cornea provides a functional barrier separating the outside environment from the intraocular environment, thereby protecting posterior segments of the eye from infection and damage. Pathological changes that compromise the structure or integrity of the cornea may occur as a result of injury or disease and can lead to debilitating effects on visual acuity. Over 10 million people worldwide are visually impaired or blind due to corneal opacity. Thus, physiologically relevant in vitro approaches to predict corneal toxicity of chemicals or effective treatments for disease prior to ocular exposure, as well as to study the corneal effects of systemic, chronic conditions, such as diabetes, are needed to reduce use of animal testing and accelerate therapeutic development. We have previously bioengineered an innervated corneal tissue model using silk protein scaffolds to recapitulate the structural and mechanical elements of the anterior cornea and to model the functional aspects of corneal sensation with the inclusion of epithelial, stromal, and neural components. The purpose of this unit is to provide a step-by-step guide for preparation, assembly, and application of this three-dimensional corneal tissue system to enable the study of corneal tissue biology. © 2019 by John Wiley & Sons, Inc.

Indexed as

CorneaSilkTissue ScaffoldsAnimal Testing AlternativesDimethylpolysiloxanesHumansTissue Culture TechniquesTissue EngineeringToxicity TestsbaysilonDimethylpolysiloxanesSilk3D in vitro modelcorneasensory nervessilk biomaterialstissue engineeringtoxicology

Identifiers

PMID31529796
PMCPMC6754119
OpenAlexW2964817122

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.